Amphastar Pharmaceuticals, Inc. Logo

Amphastar Pharmaceuticals, Inc.

Develops and manufactures complex injectable, intranasal, and inhalation pharmaceutical products.

AMPH | US

Overview

Corporate Details

ISIN(s):
US03209R1032 (+3 more)
LEI:
54930055TH0ZLSAQMJ38
Country:
United States of America
Address:
11570 SIXTH STREET, 91730 RANCHO CUCAMONGA
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Amphastar Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development, manufacturing, and marketing of complex and technically challenging pharmaceutical products. The company's portfolio primarily consists of generic and proprietary injectable, intranasal, and inhalation drugs. It specializes in complex medications, including biologics, interchangeable biosimilars, and proteins, and also manufactures its own active pharmaceutical ingredients (APIs) such as insulin. Amphastar leverages its state-of-the-art, cGMP-compliant facilities to create innovative drug delivery systems and proprietary technological platforms, targeting difficult-to-produce medications.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-06 00:00
Investor Presentation
Q3 2025 Earnings Presentation
English 3.4 MB
2025-09-03 00:00
Investor Presentation
Wells Fargo Healthcare Presentation
English 3.0 MB

Automate Your Workflow. Get a real-time feed of all Amphastar Pharmaceuticals, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Amphastar Pharmaceuticals, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Amphastar Pharmaceuticals, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Biotika A.S. Logo
Biotech firm making penicillin & polymyxin B APIs for human/vet use, plus contract manufacturing.
Slovakia
BSL
Bioton S.A. Logo
Develops and manufactures recombinant human insulin for global diabetes care solutions.
Poland
BIO
BIOVENTIX PLC Logo
Develops high-affinity sheep monoclonal antibodies for global clinical diagnostic immunoassays.
United Kingdom
BVXP
Bioversys N Logo
Develops novel therapeutics to combat antimicrobial resistance in life-threatening infections.
Switzerland
BIOV
Biovica International B Logo
Develops blood tests to monitor the efficacy of solid tumor cancer therapies.
Sweden
BIOVIC
BIOVIE INC. Logo
Develops drug therapies for Alzheimer's, Parkinson's, and advanced liver diseases by targeting inflammation.
United States of America
BIVI
BioXcel Therapeutics, Inc. Logo
AI-driven biopharma developing treatments for neuroscience and immuno-oncology.
United States of America
BTAI
Black Diamond Therapeutics, Inc. Logo
Develops precision oncology drugs targeting mutation families in lung and brain cancers.
United States of America
BDTX
BL Pharmtech Corp. Logo
Manufactures and distributes health foods, supplements, and cosmetics with bio-pharmaceutical R&D.
South Korea
065170
BOIRON Logo
Global manufacturer of homeopathic medicines for pain relief and flu-like symptoms, sold worldwide.
France
BOI

Talk to a Data Expert

Have a question? We'll get back to you promptly.